Shukla, S.; Riveros, C.; Al-Toubat, M.; Chardon-Robles, J.; Osumi, T.; Serrano, S.; Kase, A.M.; Petit, J.L.; Meurice, N.; Gleba, J.;
et al. The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth. Cancers 2023, 15, 3851.
https://doi.org/10.3390/cancers15153851
AMA Style
Shukla S, Riveros C, Al-Toubat M, Chardon-Robles J, Osumi T, Serrano S, Kase AM, Petit JL, Meurice N, Gleba J,
et al. The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth. Cancers. 2023; 15(15):3851.
https://doi.org/10.3390/cancers15153851
Chicago/Turabian Style
Shukla, Sanjeev, Carlos Riveros, Mohammed Al-Toubat, Jonathan Chardon-Robles, Teruko Osumi, Samuel Serrano, Adam M. Kase, Joachim L. Petit, Nathalie Meurice, Justyna Gleba,
and et al. 2023. "The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth" Cancers 15, no. 15: 3851.
https://doi.org/10.3390/cancers15153851
APA Style
Shukla, S., Riveros, C., Al-Toubat, M., Chardon-Robles, J., Osumi, T., Serrano, S., Kase, A. M., Petit, J. L., Meurice, N., Gleba, J., Copland, J. A., III, Chauhan, J., Fletcher, S., & Balaji, K. C.
(2023). The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth. Cancers, 15(15), 3851.
https://doi.org/10.3390/cancers15153851